HomeNews

News

Odronextamab Elicits Responses in Some With Lymphoma Following CAR-T

Amongst some sufferers with relapsed/refractory diffuse massive B-cell lymphoma whose illness progressed after CAR-T cell remedy, remedy with the bispecific antibody odronextamab has...

Advocacy and ‘Radiating Valor’ Have a Transformative Affect

From left: MATTHEW MANGOLD, B.S.N., RN, and ERIN LONGSTRETH, M.S.N., RN, OCN, NEA-BCI'm privileged to appoint Matthew Mangold, B.S.N., RN, for the Extraordinary...

Air Issues: Radon and the Atmosphere

On January 15, people gathered for the Air Issues: Radon & The Atmosphere Group Schooling Occasion.On January 15, group members, well being professionals,...

Remission is Not a Treatment for Follicular Lymphoma, or Any Most cancers

Karen Cohn is a retired center faculty particular training instructor who was recognized with follicular lymphoma in July 2020. Make amends for all...

First Affected person with CD5-Constructive T-Cell Lymphoma Dosed with MB-105

The primary affected person with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell remedy MB-105 in a part...

Hot Topics